{"id":"W2902720924","doi":"10.1097/coc.0000000000000500","title":"Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Gemcitabine; Medicine; FOLFIRINOX; Chemotherapy; Internal medicine; Oncology; Pancreatic cancer; Cancer; Irinotecan","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003115548,0.0001474041,0.0002888413,0.0003188344,0.0002179632,0.0004580126,0.0001725437,0.0002942313,0.001182425],"category_scores_gemma":[0.001743377,0.00007533286,0.0003246299,0.000572243,0.0001762463,0.0003083093,0.0002117589,0.000451989,0.0001312341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005711717,"about_ca_system_score_gemma":0.0004855322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002763879,"about_ca_topic_score_gemma":0.00465302,"domain_scores_codex":[0.9997591,0.00003473609,0.00002577559,0.00006742519,0.00005959577,0.00005341371],"domain_scores_gemma":[0.9986812,0.0001607129,0.0007748466,0.00003804955,0.00009423221,0.0002508616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002240693,0.00003728244,0.9971915,0.00001135759,0.00004179586,0.00006441797,0.00001920248,0.00008254913,0.0001238572,0.000006802443,0.0001327091,0.002064557],"study_design_scores_gemma":[0.00003431066,0.0002818121,0.9985197,0.00001171662,0.00002936205,0.000491239,0.00008197978,0.0002295289,0.00007549515,0.00002300883,0.0002185348,0.000003333891],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989204,0.0003748127,0.00004722968,0.00006389578,0.000004888323,0.000007353072,0.0002818222,0.000002425843,0.0002971791],"genre_scores_gemma":[0.9992847,0.0001106697,0.00002499343,0.00002928185,0.000009226807,0.000005799739,0.0004682576,9.127816e-7,0.00006623494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002763879,"threshold_uncertainty_score":0.005495548,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09085758571509699,"score_gpt":0.5029794401867757,"score_spread":0.4121218544716787,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}